Description
SermorelinΒ is a synthetic peptide consisting of the first 29 amino acids of growth hormone-releasing hormone (GHRH). It is studied for its ability to stimulate the pituitary gland to release natural growth hormone, supporting muscle, bone, and metabolic research.
Benefits
- Stimulates natural growth hormone release via the pituitary.
- Muscle development β studied for supporting lean body mass and recovery.
- Bone health β interest in improved bone density and strength.
- Metabolic balance β explored in fat metabolism and energy regulation research.
- Supports regenerative pathways tied to GH and IGF-1 signaling.
What researchers look at
- Mechanism: truncated GHRH fragment (1β29) with preserved biological activity.
- Stimulation of GH and downstream IGF-1 secretion.
- Comparisons to synthetic GHS (e.g., Ipamorelin, MK-677).
- Studies in aging-related GH decline and recovery research.
Quick Specs
- Form: Lyophilized peptide
- Net per vial: 5 mg
- Purity: β₯99% (HPLC)
- Identity: MS-verified (per COA)
- Storage: 2β8 Β°C, protect from light
Identity Basics
- Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
- Formula / M.W.: C149H246N46O42S, ~3357 g/mol
- CAS: 86168-78-7
Selected Research
- PubChem entry β chemical identity:
https://pubchem.ncbi.nlm.nih.gov/compound/Sermorelin
- Early GH release studies (1990s):
https://pubmed.ncbi.nlm.nih.gov/1975545/
- Clinical interest in aging-related GH decline:
https://pubmed.ncbi.nlm.nih.gov/10468979/
- Comparison with other GH secretagogues:
https://pubmed.ncbi.nlm.nih.gov/12107229/
β οΈ Disclaimer
-
This product isΒ intended for laboratory research use only.
-
Not for human or veterinary use.
-
Not approved forΒ diagnostic, therapeutic, or medical applications.
-
Handle using appropriate laboratory safety procedures and personal protective equipment.





